Richard Cunningham

Chief Executive Officer at TYME TECHNOLOGIES, INC.

54 year

Health Technology

Profile

Richard Anthony Cunningham is currently the President, Chief Executive Officer & Director at Icagen-T, Inc. He is also the Chief Executive Officer & Director at Anebulo Pharmaceuticals, Inc. and the Chief Executive Officer at Tyme Technologies, Inc. Previously, he served as the President, Chief Executive Officer & Director at Icagen, Inc. from 2014 to 2020.

Richard Cunningham active positions

Companies	Position	Start
TYME TECHNOLOGIES, INC.	Chief Executive Officer	23/11/2020
ANEBULO PHARMACEUTICALS, INC.	Chief Executive Officer	04/10/2023
Icagen-T, Inc. Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ.	Chief Executive Officer	-

All active positions of Richard Cunningham

Former positions of Richard Cunningham

Companies	Position	End
Icagen, Inc. Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC.	Chief Executive Officer	31/10/2020

See the detail of Richard Cunningham's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Cunningham's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ANEBULO PHARMACEUTICALS, INC.	Health Technology

Private companies	3
Icagen, Inc. Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC.	Health Technology
Icagen-T, Inc. Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ.	Health Technology
Tyme Technologies, Inc. Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ.	Health Technology

See company connections

Stock Market
Insiders
Richard Cunningham